China XLX’s Revenue for 9M 2022 Increased by 49% YoY Commissioning of various production bases in different regions drives the Group’s high-quality production development

EQS Newswire / 21/11/2022 / 19:03 UTC+8   China XLX’s Revenue for 9M 2022 Increased by 49% YoY Commissioning of various production bases in different regions drives the Group’s high-quality production development     Highlights of 2022 First Three Quarters Results: Revenue increased by 49% YoY to approximately RMB17,516 million. Net profit increased by 14% […]

Supermarkets facing higher costs even as revenues rise

SUPERMARKETS are dealing with higher operating costs as pandemic restrictions ease, with an industry official saying that the pickup in sales is sometimes not reflected in the resulting profits, especially for smaller stores. Steven T. Cua, Philippine Amalgamated Supermarkets Association, Inc., president, told BusinessWorld Live on One News channel that supermarkets are still adapting to […]

Sino Biopharmaceutical (1177.HK) Announces 2022 lnterim Results, Revenue up by 5.9% to RMB15.19 billion

HONG KONG, Aug 23, 2022 – (ACN Newswire via SEAPRWire.com) – Sino Biopharmaceutical Limited (“Sino Biopharmaceutical” or the “Company”, together with its subsidiaries, the “Group”) (HKEX:1177), a leading innovation-driven pharmaceutical conglomerate in the PRC, has announced its unaudited Interim results for the six months ended 30 June 2022 (the “Period”). Development Highlights— The Group achieved […]

China XLX Announces 2022 Interim Results Revenue Increased by 61% YoY

EQS Newswire / 22/08/2022 / 10:32 UTC+8   China XLX Announces 2022 Interim Results Revenue Increased by 61% YoY     2022 Interim Results Highlights:   Revenue increased by 61% YoY to approximately RMB12,214 million. Gross profit increased by 44% YoY to approximately RMB3,060 million. Net Profit increased by 47% YoY to approximately RMB1,304 million. […]

TOT BIOPHARM Reached New Milestones in Interim Results, with Sales Volume of over RMB 100 million, a Significantly Improved Capital Structure

EQS Newswire / 15/08/2022 / 10:26 UTC+8 TOT BIOPHARM Reached New Milestones in Interim Results, with Sales Volume of over RMB 100 million, a Significantly Improved Capital Structure A Year-on-Year Increase of 687% in Operating Revenue to RMB 182 million, and a Year-on-Year Decrease of 86% in Net Loss to RMB 15.72 million On 12 […]

Three local companies enter Forbes’ under a billion list

Three Philippine companies — COL Financial Group, Inc., Crown Asia Chemicals Corp. and Eagle Cement Corp. — are among Forbes Asia’s roster of top-performing publicly traded small and midsized firms in the Asia-Pacific region this year. The annual “Forbes Asia’s Best Under A Billion,” identifies the top 200 companies out of 20,000 publicly listed firms in the […]

Wilcon net profit climbs 56% to P1B

WILCON Depot, Inc. reported a 56.4% increase in net profit to P1.01 billion in the second quarter as sales increased amid eased pandemic restrictions. “The jump is attributable to higher volume of business and to the gross profit margin expansion partly offset by the increase in operating expenses,” the company said in a press release […]

Toyota Announces Sales, Production, and Export Results for the First Half of 2022

Toyota City, Japan, Jul 28, 2022 – (JCN Newswire via SEAPRWire.com) – Toyota Motor Corporation (TMC) announces its sales, production, and export results for June 2022 as well as the cumulative total from January to June, including those for subsidiaries Daihatsu Motor Co., Ltd. and Hino Motors, Ltd. Highlights: In the first half of 2022, […]